Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance

Details for Australian Patent Application No. 2003248284 (hide)

Owner Thromb-X.N.V. Collen, D.

Inventors Collen, Desire Jose

Agent Baldwin Shelston Waters

Pub. Number AU-A-2003248284

Parent 25219

Filing date 12 September 2003

Wipo publication date 30 October 2003

International Classifications

C12N 015/31 Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C07K 014/31 Peptides having more than 20 amino acids

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

9 October 2003 Complete Application Filed

30 October 2003 Application Open to Public Inspection

  Published as AU-A-2003248284

20 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003248285-Compositions for exfoliating skin and treating blackheads

2003248283-Parking system for sending messages